These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35174087)

  • 1. The Prognostic and Predictive Role of Xeroderma Pigmentosum Gene Expression in Melanoma.
    Fischer S; Hamed M; Emmert S; Wolkenhauer O; Fuellen G; Thiem A
    Front Oncol; 2022; 12():810058. PubMed ID: 35174087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma.
    Zhang W; Xia H; Yang R; Zhang Y; Zheng Q; Shang X; Liu N; Ma X; Wei C; Chen H; Mu X; Wang X; Liu Y
    Front Immunol; 2022; 13():1030969. PubMed ID: 36426352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers.
    Fernandez ER; Tamura D; Khan SG; Momen S; Fassihi H; Sarkany R; DiGiovanna JJ; Kraemer KH
    Front Oncol; 2023; 13():1282823. PubMed ID: 37954081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous CRISPR/Cas9 Knockout Generated a Novel Functionally Active Exon 1 Skipping XPA Variant in Melanoma Cells.
    Banicka V; Martens MC; Panzer R; Schrama D; Emmert S; Boeckmann L; Thiem A
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
    Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
    Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CARD11 alteration as a candidate biomarker of skin cutaneous melanoma treated with immune checkpoint blockade.
    Si Y; Lin A; Ding W; Meng H; Luo P; Zhang J
    Am J Transl Res; 2021; 13(1):286-300. PubMed ID: 33527024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Infiltrating PD-1
    Yang Z; Deng Y; Cheng J; Wei S; Luo H; Liu L
    Front Oncol; 2021; 11():695006. PubMed ID: 34604032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma.
    Chikhaoui A; Jones M; Režen T; Ben Ahmed M; Naouali C; Komel R; Zghal M; Boubaker S; Abdelhak S; Yacoub-Youssef H
    Sci Rep; 2022 Aug; 12(1):13854. PubMed ID: 35974070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous recombination repair gene mutations as a predictive biomarker for immunotherapy in patients with advanced melanoma.
    You Z; Lv M; He X; Pan Y; Ge J; Hu X; Zheng Y; Huang M; Zhou C; You C
    Front Immunol; 2022; 13():871756. PubMed ID: 35990677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review.
    Jessurun CAC; Vos JAM; Limpens J; Luiten RM
    Front Oncol; 2017; 7():233. PubMed ID: 29034210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
    Martens MC; Emmert S; Boeckmann L
    Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3.
    Vermeulen W; Scott RJ; Rodgers S; Müller HJ; Cole J; Arlett CF; Kleijer WJ; Bootsma D; Hoeijmakers JH; Weeda G
    Am J Hum Genet; 1994 Feb; 54(2):191-200. PubMed ID: 8304337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
    Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
    G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.